<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>1130-0108</journal-id>
<journal-title><![CDATA[Revista Española de Enfermedades Digestivas]]></journal-title>
<abbrev-journal-title><![CDATA[Rev. esp. enferm. dig.]]></abbrev-journal-title>
<issn>1130-0108</issn>
<publisher>
<publisher-name><![CDATA[Sociedad Española de Patología Digestiva]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S1130-01082009000300005</article-id>
<title-group>
<article-title xml:lang="en"><![CDATA[Results of a survey about specific inflammatory bowel disease units in Andalusia]]></article-title>
<article-title xml:lang="es"><![CDATA[Resultados de la encuesta sobre consulta monográfica de enfermedad inflamatoria intestinal realizada en Andalucía]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Herrerías Gutiérrez]]></surname>
<given-names><![CDATA[J. M.]]></given-names>
</name>
<xref ref-type="aff" rid="A01"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Argüelles Arias]]></surname>
<given-names><![CDATA[F.]]></given-names>
</name>
<xref ref-type="aff" rid="A01"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Moreno Gallego]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<xref ref-type="aff" rid="A02"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Dios Vega]]></surname>
<given-names><![CDATA[J. de]]></given-names>
</name>
<xref ref-type="aff" rid="A03"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Martín-Vivaldi Martínez]]></surname>
<given-names><![CDATA[R.]]></given-names>
</name>
<xref ref-type="aff" rid="A04"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Domínguez Macías]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
<xref ref-type="aff" rid="A05"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Sánchez Cantos]]></surname>
<given-names><![CDATA[A. M.]]></given-names>
</name>
<xref ref-type="aff" rid="A06"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Ferré Álamo]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
<xref ref-type="aff" rid="A07"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Manteca]]></surname>
<given-names><![CDATA[R.]]></given-names>
</name>
<xref ref-type="aff" rid="A08"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Vega Sáenz]]></surname>
<given-names><![CDATA[J. L.]]></given-names>
</name>
<xref ref-type="aff" rid="A09"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Romero Gómez]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<xref ref-type="aff" rid="A10"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Márquez Galán]]></surname>
<given-names><![CDATA[J. L.]]></given-names>
</name>
<xref ref-type="aff" rid="A11"/>
</contrib>
</contrib-group>
<aff id="A01">
<institution><![CDATA[,Virgen Macarena Hospital Service of Digestive Diseases ]]></institution>
<addr-line><![CDATA[Sevilla ]]></addr-line>
<country>Spain</country>
</aff>
<aff id="A02">
<institution><![CDATA[,Puerta del Mar Hospital  ]]></institution>
<addr-line><![CDATA[Cádiz ]]></addr-line>
<country>Spain</country>
</aff>
<aff id="A03">
<institution><![CDATA[,Reina Sofía Hospital  ]]></institution>
<addr-line><![CDATA[Córdoba ]]></addr-line>
<country>Spain</country>
</aff>
<aff id="A04">
<institution><![CDATA[,Virgen de las Nieves Hospital  ]]></institution>
<addr-line><![CDATA[Granada ]]></addr-line>
<country>Spain</country>
</aff>
<aff id="A05">
<institution><![CDATA[,Juan Ramón Jiménez Hospital  ]]></institution>
<addr-line><![CDATA[Huelva ]]></addr-line>
<country>Spain</country>
</aff>
<aff id="A06">
<institution><![CDATA[,Costa del Sol Hospital  ]]></institution>
<addr-line><![CDATA[Marbella ]]></addr-line>
<country>Spain</country>
</aff>
<aff id="A07">
<institution><![CDATA[,Hospital de Jerez  ]]></institution>
<addr-line><![CDATA[Jerez ]]></addr-line>
<country>Spain</country>
</aff>
<aff id="A08">
<institution><![CDATA[,Carlos Haya Regional Hospital  ]]></institution>
<addr-line><![CDATA[Málaga ]]></addr-line>
<country>Spain</country>
</aff>
<aff id="A09">
<institution><![CDATA[,Torrecárdenas Hospital  ]]></institution>
<addr-line><![CDATA[Almería ]]></addr-line>
<country>Spain</country>
</aff>
<aff id="A10">
<institution><![CDATA[,Nuestra Señora de Valme Hospital  ]]></institution>
<addr-line><![CDATA[Sevilla ]]></addr-line>
<country>Spain</country>
</aff>
<aff id="A11">
<institution><![CDATA[,Virgen del Rocío University Hospital  ]]></institution>
<addr-line><![CDATA[Sevilla ]]></addr-line>
<country>Spain</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>03</month>
<year>2009</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>03</month>
<year>2009</year>
</pub-date>
<volume>101</volume>
<numero>3</numero>
<fpage>187</fpage>
<lpage>191</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://scielo.isciii.es/scielo.php?script=sci_arttext&amp;pid=S1130-01082009000300005&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.isciii.es/scielo.php?script=sci_abstract&amp;pid=S1130-01082009000300005&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.isciii.es/scielo.php?script=sci_pdf&amp;pid=S1130-01082009000300005&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="en"><p><![CDATA[Background: inflammatory bowel disease (IBD) has become one of the most prevalent pathologies in Gastroenterology Units, which added to its clinical outcome, treatment, the complexity of affected patients and the need to be continuously updated for the correct management of the disease, have made essential the presence of specific IBD units in each hospital. Objectives: the primary aims of this study were: a) to reveal the existence of these units in our area and how they work; and b) to draw conclusions regarding the necessary resources in these units and their aims. Material and methods: In order to analyse the presence of these specialized units and the available resources in Andalusian hospitals, a 24-question survey was designed, being answered by 11 hospitals. The evaluated questions included the number of days patients are attended and the number of physicians attending the unit, the number of available healthcare assistants, if emergencies are attended or not, if there is an activated telephone number for patient consultation, if a day care unit is available and if new treatments are easily accessible. Results: a specific IBD unit is present in all studied hospitals attending more than 11 patients each, although in the 63.4% of the cases patients are not attended more than 3 days per week. On the other hand, the 81.8% of the included hospitals attend emergencies although only the 54.5% of them had a specific telephone number for patient attendance. Conclusions: a specific IBD unit is present in many Andalusian hospitals, although some deficiencies can be observed. The general opinion of this Group is that these units are necessary in order to properly attend, monitorize and treat patients affected by IBD.]]></p></abstract>
<abstract abstract-type="short" xml:lang="es"><p><![CDATA[Introducción: la enfermedad inflamatoria intestinal (EII) se está convirtiendo en una de las patologías más prevalentes en las consultas de digestivo. Esta mayor prevalencia de la enfermedad, su evolución, tratamiento y el tipo de pacientes cada vez más complejos, junto a la necesidad de conocer las últimas novedades para poder atenderlos correctamente, hace pensar en la necesidad de tener una consulta específica de esta entidad. Objetivos: a) conocer si existen este tipo de consultas en nuestro medio y cómo se desarrollan; y b) elaborar una serie de conclusiones sobre la infraestructura necesaria y los objetivos de la misma. Material y métodos: se ha realizado una encuesta de 24 preguntas en las que se analiza la existencia o no de este tipo de consulta en los hospitales andaluces, así como de los medios con los que cuentan. Han respondido a la misma 11 hospitales. Se analizan cuestiones como el número de días que se pasa la consulta y el número de médicos que las atiende, el personal auxiliar con el que se cuenta, si se atienden urgencias o existe línea telefónica de consultas, y si se dispone de Unidad de Día o acceso a las últimas líneas de tratamiento, entre otras. Resultados: en todos los hospitales encuestados existe consulta monográfica. En todos ellos se ven más de 11 enfermos en cada consulta, si bien, en el 63,6% de los casos esta consulta no se pasa más de 3 días a la semana. Por otro lado, el 81,8% de los hospitales atiende urgencias pero sólo el 54,5% de los encuestados tiene línea telefónica para atender a sus pacientes. Conclusiones: la consulta monográfica de EII está extendida en Andalucía, aunque existen algunas deficiencias en las mismas. Este grupo de trabajo cree que este tipo de consulta es necesaria para la atención, seguimiento y el tratamiento correcto de los pacientes con EII.]]></p></abstract>
<kwd-group>
<kwd lng="en"><![CDATA[Inflammatory bowel disease]]></kwd>
<kwd lng="en"><![CDATA[IBD Unit]]></kwd>
<kwd lng="en"><![CDATA[Croh's disease]]></kwd>
<kwd lng="en"><![CDATA[Ulcerative colitis]]></kwd>
<kwd lng="es"><![CDATA[Enfermedad inflamatoria intestinal]]></kwd>
<kwd lng="es"><![CDATA[Unidad de EII]]></kwd>
<kwd lng="es"><![CDATA[Enfermedad de Crohn]]></kwd>
<kwd lng="es"><![CDATA[Colitis ulcerosa]]></kwd>
</kwd-group>
</article-meta>
</front><body><![CDATA[ <p align="right"><font face="Verdana" size="2"><b><a name="top"></a>ORIGINAL PAPERS</b></font></p>     <p>&nbsp;</p>     <p><font face="Verdana" size="4"><b>Results of a survey about specific inflammatory bowel disease units in Andalusia</b></font></p>     <p><font face="Verdana" size="4"><b>Resultados de la encuesta sobre consulta monográfica de enfermedad inflamatoria intestinal realizada en Andalucía</b></font></p>     <p>&nbsp;</p>     <p>&nbsp;</p>     <p>&nbsp;</p>     <p><font face="Verdana" size="2"><b>J. M. Herrer&iacute;as Guti&eacute;rrez, F. Arg&uuml;elles Arias, M. Moreno Gallego<sup>1</sup>, J. de Dios Vega<sup>2</sup>, R. Mart&iacute;n-Vivaldi Mart&iacute;nez<sup>3</sup>, A. Dom&iacute;nguez Mac&iacute;as<sup>4</sup>, A. M. S&aacute;nchez Cantos<sup>5</sup>, A. Ferr&eacute; &Aacute;lamo<sup>6</sup>, R. Manteca<sup>7</sup>, J. L. Vega S&aacute;enz<sup>8</sup>, M. Romero G&oacute;mez<sup>9</sup> and J. L. M&aacute;rquez Gal&aacute;n<sup>10</sup></b></font></p>     <p><font face="Verdana" size="2">Service of Digestive Diseases. Virgen Macarena Hospital. Sevilla, Spain.    <br><sup>1</sup>Puerta del Mar Hospital. C&aacute;diz, Spain.    ]]></body>
<body><![CDATA[<br><sup>2</sup>Reina Sof&iacute;a Hospital. C&oacute;rdoba, Spain.    <br><sup>3</sup>Virgen de las Nieves Hospital. Granada, Spain.    <br><sup>4</sup>Juan Ram&oacute;n Jim&eacute;nez Hospital. Huelva, Spain.    <br><sup>5</sup>Costa del Sol Hospital. Marbella, M&aacute;laga. Spain.    <br><sup>6</sup>Hospital de Jerez. C&aacute;diz, Spain.    <br><sup>7</sup>Carlos Haya Regional Hospital. M&aacute;laga, Spain.    <br><sup>8</sup>Torrec&aacute;rdenas Hospital. Almer&iacute;a, Spain.    <br><sup>9</sup>Nuestra Se&ntilde;ora de Valme Hospital. Sevilla, Spain.    <br><sup>10</sup>Virgen del Roc&iacute;o University Hospital. Sevilla, Spain.    <br>Andalusian Team of Chiefs of Gastroenterology Units and Departments</font></p>     ]]></body>
<body><![CDATA[<p><font face="Verdana" size="2"><a href="#bajo">Correspondence</a></font></p>     <p>&nbsp;</p>     <p>&nbsp;</p><hr size="1">     <p><font face="Verdana" size="2"><b>ABSTRACT</b></font></p>     <p><font face="Verdana" size="2"><b>Background:</b> inflammatory bowel disease (IBD) has become one of the most prevalent pathologies in Gastroenterology Units, which added to its clinical outcome, treatment, the complexity of affected patients and the need to be continuously updated for the correct management of the disease, have made essential the presence of specific IBD units in each hospital.    <br><b>Objectives:</b> the primary aims of this study were: a) to reveal the existence of these units in our area and how they work; and b) to draw conclusions regarding the necessary resources in these units and their aims.    <br><b>Material and methods:</b> In order to analyse the presence of these specialized units and the available resources in Andalusian hospitals, a 24-question survey was designed, being answered by 11 hospitals. The evaluated questions included the number of days patients are attended and the number of physicians attending the unit, the number of available healthcare assistants, if emergencies are attended or not, if there is an activated telephone number for patient consultation, if a day care unit is available and if new treatments are easily accessible.    <br><b>Results:</b> a specific IBD unit is present in all studied hospitals attending more than 11 patients each, although in the 63.4% of the cases patients are not attended more than 3 days per week. On the other hand, the 81.8% of the included hospitals attend emergencies although only the 54.5% of them had a specific telephone number for patient attendance.    <br><b>Conclusions:</b> a specific IBD unit is present in many Andalusian hospitals, although some deficiencies can be observed. The general opinion of this Group is that these units are necessary in order to properly attend, monitorize and treat patients affected by IBD.</font></p>     <p><font face="Verdana" size="2"><b>Key words:</b> Inflammatory bowel disease. IBD Unit. Croh's disease. Ulcerative colitis.</font></p> <hr size="1">     ]]></body>
<body><![CDATA[<p><font face="Verdana" size="2"><b>RESUMEN</b></font></p>     <p><font face="Verdana" size="2"><b>Introducci&oacute;n:</b> la enfermedad inflamatoria intestinal (EII) se est&aacute; convirtiendo en una de las patolog&iacute;as m&aacute;s prevalentes en las consultas de digestivo. Esta mayor prevalencia de la enfermedad, su evoluci&oacute;n, tratamiento y el tipo de pacientes cada vez m&aacute;s complejos, junto a la necesidad de conocer las &uacute;ltimas novedades para poder atenderlos correctamente, hace pensar en la necesidad de tener una consulta espec&iacute;fica de esta entidad.    <br><b>Objetivos:</b> a) conocer si existen este tipo de consultas en nuestro medio y c&oacute;mo se desarrollan; y b) elaborar una serie de conclusiones sobre la infraestructura necesaria y los objetivos de la misma.    <br><b>Material y m&eacute;todos:</b> se ha realizado una encuesta de 24 preguntas en las que se analiza la existencia o no de este tipo de consulta en los hospitales andaluces, as&iacute; como de los medios con los que cuentan. Han respondido a la misma 11 hospitales. Se analizan cuestiones como el n&uacute;mero de d&iacute;as que se pasa la consulta y el n&uacute;mero de m&eacute;dicos que las atiende, el personal auxiliar con el que se cuenta, si se atienden urgencias o existe l&iacute;nea telef&oacute;nica de consultas, y si se dispone de Unidad de D&iacute;a o acceso a las &uacute;ltimas l&iacute;neas de tratamiento, entre otras.    <br><b>Resultados:</b> en todos los hospitales encuestados existe consulta monogr&aacute;fica. En todos ellos se ven m&aacute;s de 11 enfermos en cada consulta, si bien, en el 63,6% de los casos esta consulta no se pasa m&aacute;s de 3 d&iacute;as a la semana. Por otro lado, el 81,8% de los hospitales atiende urgencias pero s&oacute;lo el 54,5% de los encuestados tiene l&iacute;nea telef&oacute;nica para atender a sus pacientes.    <br><b>Conclusiones:</b> la consulta monogr&aacute;fica de EII est&aacute; extendida en Andaluc&iacute;a, aunque existen algunas deficiencias en las mismas. Este grupo de trabajo cree que este tipo de consulta es necesaria para la atenci&oacute;n, seguimiento y el tratamiento correcto de los pacientes con EII.</font></p>     <p><font face="Verdana" size="2"><b>Palabras clave:</b> Enfermedad inflamatoria intestinal. Unidad de EII. Enfermedad de Crohn. Colitis ulcerosa.</font></p> <hr size="1">     <p>&nbsp;</p>     <p><font face="Verdana"><b>Introduction</b></font></p>     <p><font face="Verdana" size="2">Inflammatory bowel disease (IBD) has emerged as one the most prevalent in Gastroenterlogy Units. Therefore, and despite being only two causal entities, clinical outcome, treatment and the complexity of affected patients have made a specific IBD unit essential in many hospitals. It is estimated that prevalence rates in Northern Europe and North America varies between 100 and 200 cases per 100,000 people (1-4). In Spain, the incidence of ulcerative colitis (UC) varies from 0,6 to 8 cases per 100,000 people and year and Crohn's disease (CD) varies from 0.4 to 5.5 cases per 100,000 people and year (5) and, according to Saro et al., the prevalence of IBD in Asturias is 16.55 being 9.52 for UC and 5.95 for CD (6). In Andalusia, there are no published data concerning IBD prevalence, although there is a study carried out in Huelva in which IBD incidence was estimated to be 5.2 per 100,000 people and year for UC and 6.6 cases for CD per 100,000 people and year (7). According to IBD's white paper (8) the prospects for 2010 announce more than 800,000 new cases of IBD, counting for more than 118,000 patients.</font></p>     ]]></body>
<body><![CDATA[<p><font face="Verdana" size="2">On the other hand, the costs derived from each IBD patient can be reduced throughout these units due to a lower number of visits to the Emergency Room (ER) and, therefore, the number of admissions to hospital. A specific unit reduces direct costs of the disease, especially those derived from hospital admissions, and indirect costs, related to patients not attending their jobs, being cost-effective (9).</font></p>    <p> <font face="Verdana" size="2">Furthermore, the introduction of biological treatments and a broad range of new therapeutic tools, as well as potential complications of the disease, not only digestive but also extraintestinal, increase the need of creating or having units exclusively dedicated to this pathology. Finally, there is an increasing demand of personalized attention by patients, with an appropriate doctor-patient relationship, and offering the possibility of "on demand" consultations, in order to avoid attending ERs. Nevertheless, these units have not been created in many Gastroenterology Units due to a lack of infrastructure. Following previous publications (10,11), one of the purposes of this survey was to study these units in Andalusia.</font></p>     <p>&nbsp;</p>     <p><font face="Verdana"><b>Objectives</b></font></p>     <p><font face="Verdana" size="2">The primary aims of this study were:</font></p>     <p><font face="Verdana" size="2">-To reveal the existence of these units in our area and how they work.</font></p>     <p><font face="Verdana" size="2">-To draw conclusions regarding the necessary resources in these units and their aims.</font></p>     <p>&nbsp;</p>     <p><font face="Verdana"><b>Material and methods</b></font></p>     <p><font face="Verdana" size="2">A survey regarding IBD units was designed, and a descriptive analysis of answers submitted by 11 Andalusian hospitals - H.U. "Virgen de Valme", "Virgen del Roc&iacute;o", and "Virgen Macarena" in Seville; H. SAS Jerez and "Puerta del Mar" in C&aacute;diz; H. Costa del Sol (Marbella) and H.U. "Carlos Haya" in M&aacute;laga; H.U. "Virgen de las Nieves" in Granada; H. "Juan Ram&oacute;n Jim&eacute;nez" in Huelva; H.U. "Reina Sof&iacute;a" in C&oacute;rdoba, and H. "Torrec&aacute;rdenas" in Almer&iacute;a - was carried out. The survey consisted of 24 questions with one possible answer out of several options in order to assess not only the units' current status but also their ideal conditions.</font></p>     ]]></body>
<body><![CDATA[<p><font face="Verdana" size="2"><b>Survey</b></font></p>     <p><font face="Verdana" size="2"><i><b>Questions</b></i></font></p>     <p><font face="Verdana" size="2">1. <i>How many users does your unit cover?</i>    <br>Fewer than 100,000 people; between 100,000 and 250,000 people; between 250,000 and 400,000 people; more than 400,000 people.</font></p>     <p><font face="Verdana" size="2">2. <i>Is there a specific IBD unit in your hospital?</i>    <br>Yes; No.</font></p>     <p><font face="Verdana" size="2">3. <i>How many patients are cared for daily in your unit?</i>    <br>Fewer than 10; between 11 and 20; between 21 and 30; more than 31.</font></p>     <p><font face="Verdana" size="2">4. <i>How many patients should be cared for daily?</i>    <br>Fewer than 10; between 11 and 20; between 21 and 30; more than 31.</font></p>     ]]></body>
<body><![CDATA[<p><font face="Verdana" size="2">5. <i>How many days a week are patients seen in these units?</i>    <br>1; 2; 3; 4; 5.</font></p>     <p><font face="Verdana" size="2">6. <i>How many days a week should patients be seen?</i>    <br>1; 2; 3; 4; 5.</font></p>     <p><font face="Verdana" size="2">7. <i>How many doctors are there attending this unit?</i>    <br>1; 2; 3; 4.</font></p>     <p>    <p><font face="Verdana" size="2">8. <i>How many doctors should there be attending this unit?</i>    <br>1; 2; 3; 4.</font></p>     <p><font face="Verdana" size="2">9. <i>Do you have healthcare assistants of your own?</i>    ]]></body>
<body><![CDATA[<br>No; Yes.</font></p>     <p><font face="Verdana" size="2">10. <i>Do you think your unit should have their own healthcare assistants?</i>    <br>No; Yes.</font></p>     <p><font face="Verdana" size="2">11. <i>Does your unit have emergency care?</i>    <br>Yes; No.</font></p>     <p><font face="Verdana" size="2">12. <i>Do you think your unit should have emergency care?</i>    <br>Yes; No.</font></p>     <p><font face="Verdana" size="2">13. <i>Is there an available telephone hotline for patient care?</i>    <br>No; Yes.</font></p>     <p><font face="Verdana" size="2">14. <i>Do you think there should be a telephone hotline for patient care?</i>    ]]></body>
<body><![CDATA[<br>No; Yes.</font></p>     <p><font face="Verdana" size="2">15. <i>Are there any day care units in your hospital?</i>    <br>Yes; No.</font></p>     <p><font face="Verdana" size="2">16. <i>Do you think there should be day care units in your hospital?</i>    <br>No; Yes.</font></p>     <p><font face="Verdana" size="2">17. <i>Is your unit computerized?</i>    <br>Yes; No.</font></p>     <p><font face="Verdana" size="2">18. <i>Do you think it should be?</i>    <br>Yes; No.</font></p>     <p><font face="Verdana" size="2">19. <i>Is your unit provided with patient records?</i>    ]]></body>
<body><![CDATA[<br>No; Yes.</font></p>     <p><font face="Verdana" size="2">20. <i>Do you think your unit should have patient records?</i>    <br>No; Yes.</font></p>     <p><font face="Verdana" size="2">21. <i>Are any clinical trials carried out?</i>    <br>No; Yes.</font></p>     <p><font face="Verdana" size="2">22. <i>Do you think there should be clinical trials performed?</i>    <br>No; Yes.</font></p>     <p><font face="Verdana" size="2">23. <i>Are new treatments easily available?</i>    <br>Yes; No.</font></p>     <p><font face="Verdana" size="2">24. <i>Dou you think they should be?</i>    ]]></body>
<body><![CDATA[<br>Yes; No.</font></p>     <p>&nbsp;</p>     <p><font face="Verdana"><b>Results</b></font></p>     <p><font face="Verdana" size="2">1. <i>How many users does your unit cover?</i>    <br><i>Answer:</i> 6 hospitals (54.5%) cover a population with more than 400,000 people; and 5 hospitals cover between 250,000 and 400,000.</font></p>     <p><font face="Verdana" size="2">2. <i>Is there a specific IBD unit in your hospital?</i>    <br><i>Answer:</i> all hospitals have an IBD unit.</font></p>     <p><font face="Verdana" size="2">3. <i>How many patients are cared for daily in your unit?</i>    <br><i>Answer:</i> 5 hospitals (45.4%) care for between 21 and 30; and 6 hospitals for between 11 and 20.</font></p>     <p><font face="Verdana" size="2">4. <i>How many patients should be daily cared for?</i>    ]]></body>
<body><![CDATA[<br><i>Answer:</i> ten hospitals (90.9%) think that between 11 and 20 patients; and one hospital thinks that fewer than 10.</font></p>     <p><font face="Verdana" size="2">5. <i>How many days a week are visits scheduled in the IBD unit?</i>    <br><i>Answer:</i> in 3 hospitals (27.3%), visits are scheduled once a week; in 4 hospitals (36.4%) 3 days a week; in 1 hospital 4 days a week; and in 3 hospitals (27.3%) 5 days a week.</font></p>     <p><font face="Verdana" size="2">6. <i>How many days a week should they be scheduled?</i>    <br><i>Answer:</i> three hospitals (27.3%) consider that they should be scheduled twice a week; 3 hospitals that 3 days a week; 2 hospitals consider that 4 days a week; and 3 hospitals consider that 5 days a week.</font></p>     <p><font face="Verdana" size="2">7. <i>How many doctors are there attending this unit?</i>    <br><i>Answer:</i> in 5 hospitals (45.4%) only one doctor is attending the unit; in 4 hospitals (36.4%) two doctors attend the unit; and in 2 hospitals three doctors attend the unit.</font></p>     <p><font face="Verdana" size="2">8. <i>How many doctors should there be attending this unit?</i>    <br><i>Answer:</i> five hospitals (45.4%) consider that there should be 2 doctors attending the unit; four hospitals (36.4%) think that 3 doctors; and 2 hospitals (18.2%) think that more than 3 doctors.</font></p>     <p><font face="Verdana" size="2">9. <i>Do you have healthcare assistants of your own?</i>    ]]></body>
<body><![CDATA[<br><i>Answer:</i> three hospitals (27.3%) have their own healthcare assistants; and 8 hospitals (72.7%) do not have them.</font></p>     <p><font face="Verdana" size="2">10. <i>Do you think your unit should have healthcare assistants of its own?</i>    <br><i>Answer:</i> ten hospitals (90.9%) think that they should; and one hospital think that they should not.</font></p>     <p><font face="Verdana" size="2">11. <i>Does your unit have emergency care?</i>    <br><i>Answer:</i> nine hospitals (81.8%) have emergency care; and 2 hospitals have no emergency care.</font></p>     <p><font face="Verdana" size="2">12. <i>Do you think your unit should have emergency care?</i>    <br><i>Answer:</i> ten hospitals (90.9%) think that emergency care should be included; and one hospital considers it should be not included.</font></p>     <p><font face="Verdana" size="2">13. <i>Is there an available telephone hotline for patient care?</i>    <br><i>Answer:</i> in 5 hospitals (45.4%) it is not available; and in 6 hospitals it is.</font></p>     <p><font face="Verdana" size="2">14. <i>Do you think there should be a telephone hotline for patient attendance?</i>    ]]></body>
<body><![CDATA[<br><i>Answer:</i> two hospitals do not consider it necessary; and 9 hospitals (81.8%) do consider it necessary.</font></p>     <p><font face="Verdana" size="2">15. <i>Are there day care units in your hospital?</i>    <br><i>Answer:</i> there are day care units in every hospital.</font></p>     <p><font face="Verdana" size="2">16. <i>Do you think there should be day care units in your hospital?</i>    <br><i>Answer:</i> every hospital thinks that there should be one.</font></p>     <p><font face="Verdana" size="2">17. <i>Is your unit computerized?</i>    <br><i>Answer:</i> in five hospitals (45.5%) units are not computerized; and 6 have computerized units.</font></p>     <p><font face="Verdana" size="2">18. <i>Do you think it should be?</i>    <br><i>Answer:</i> all hospitals think that they should be computerized.</font></p>     <p><font face="Verdana" size="2">19. <i>Is your unit provided with patient records?</i>    ]]></body>
<body><![CDATA[<br><i>Answer:</i> four hospitals (36.4%) are not provided with patient records; and 7 hospitals (63.6%) do have them.</font></p>     <p><font face="Verdana" size="2">20. <i>Do you think your unit should have patient records?</i>    <br><i>Answer:</i>all hospitals think that there should be patient records available.</font></p>     <p><font face="Verdana" size="2">21. <i>Are any clinical trials carried out?</i>    <br><i>Answer:</i>none in 2 hospitals, yes in 9 hospitals (81.8%).</font></p>     <p><font face="Verdana" size="2">22. <i>Do you think they should be done?</i>    <br><i>Answer:</i>two hospitals (18.2%) think that clinical trials should not be done; and 9 hospitals think that they should.</font></p>     <p><font face="Verdana" size="2">23. <i>Are new treatments easily available?</i>    <br><i>Answer:</i> all hospitals have an easy access to new treatments.</font></p>     <p><font face="Verdana" size="2">24. <i>Dou you think they should be?</i>    ]]></body>
<body><![CDATA[<br><i>Answer:</i> all hospitals think that they should be.</font></p>     <p>&nbsp;</p>     <p><font face="Verdana"><b>Discussion</b></font></p>     <p><font face="Verdana" size="2">A specific IBD unit is one exclusively dedicated to evaluate, monitor, and treat patients affected by this pathology. Over the last years, the presence of these units has become essential, not only due to the rising incidence and prevalence of IBD, and to the appearance of new treatment options, but also to the low associated mortality, as it has become a chronic disease. Otherwise, easy access for patients to information regarding IBD, such as the Internet, generates a need for attending physicians to be continuously updated (12).</font></p>     <p><font face="Verdana" size="2">This survey was done following a workflow similar to that of previously published studies carried out by this Group (10,11). One of the main aims was to know if IBD units were present in Andalusian hospitals and their daily job development. In the first place, we must point out that this survey has been answered by third-level hospitals, except Hospital de Jerez (C&aacute;diz). This implies a bias in patient selection as only hospitals covering more than 250,000 people were included, which, due to a higher number of patients with IBD, increases the demand for these units. Nevertheless, it is worth noting that all surveyed hospitals count on these units, with more than 11 patients in each office. According to the received answers, seeing more than 20 patients turns out to be quite excessive owing to their complexity and, overall, to the intended use of these units in making scheduled visits compatible with emergency patients. In most of the studied hospitals these units are attended more than twice a week, which is in agreement with the general opinion that they should be attended at least twice a week, depending on demand. In each unit, visits are attended by one or two doctors, although most hospitals consider necessary the presence of at least two doctors. It is important to point out that most of these units do not have healthcare assistants of their own, which makes the correct management of these patients a difficult issue. It has been observed that the presence of a specialized nurse increases effectiveness (13), reducing visits to hospital by up to 38%, increasing patients in remission, and enhancing the quality of life of attended patients.</font></p>     <p><font face="Verdana" size="2">Doubtlessly, an important matter in a specific IBD unit is seeing emergency patients, which is done in most hospitals. According to Casellas et al. (14), 79.6% of patients have visited at least once the ER, and 38% of these visits could have been avoided with a better understanding of the disease or telephonic consultation. This reinforces the utility and need of a specific unit that may offer the possibility of attending emergency patients either in person or via a dedicated telephone number (15). Adequate knowledge of this pathology by patients and scheduled visits increase quality of life and reduce costs derived from this disease as well (16). The usual fixed appointment system rarely provides coincidence of attendance and disease relapse, adverse events derived from drugs, and so on. Another important issue in the correct management of these units is a high level of doctor-patient relationship, providing information over the telephone or directly in the unit, and allowing these patients to perfectly understand the disease including self-medication (17,18).</font></p>     <p><font face="Verdana" size="2">In all studied hospitals there is a day care unit, which is necessary for certain treatments. However, there is much more heterogeneity regarding other resources such as unit computerization or the presence of patient records, and it is unquestionable that clinical trials and extended access to new treatments are critical for the correct management of patients, especially the most complex ones.</font></p>     <p><font face="Verdana" size="2">Cooperation with other medical specialists has not been included in this survey, although IBD units must be supported by an interdisciplinary group. According to the white paper on IBD, by 2010 IBD units will be attended by different medical specialists including rheumatologists, ophthalmologists, hematologists, etc., to establish rapid and effective clinical practice. Interconsultation and clinical sessions carried out in conjunction with other medical specialists are also essential. Among other functions, it is also remarkable that these units may be useful to achieve adequate relationships with patient associations or the GETECCU group, and to improve information spread and teaching about this disease.</font></p>     <p><font face="Verdana" size="2">After analyzing the results obtained, an IBD specific unit seems to be necessary in every hospital with a general Gastroenterology Unit. In these units, patients should be seen at least twice a week, no fewer than 2 doctors should be attending visits, healthcare assistants should be qualified and work exclusively in the unit, a telephone hotline should be available for non-visiting patients, and these units should be capable of attending emergencies without interrupting their daily work. In the same manner, computerized units provided with patient records and the ability to access new treatments and clinical trials are necessary to consider IBD units complete.</font></p>     <p><font face="Verdana" size="2">The main aim of this unit is to achieve complete management, including follow-up and treatment response monitoring, for patients with IBD as well as an appropriate doctor-patient relationship. It is important that these units are manned not only by gastroenterologists, but also by other medical specialists such as surgeons, rheumatologists, dermatologists, ophthalmologists, and hematologists to dynamize consultations and facilitate periodical clinical sessions in order to make correct decisions.</font></p>     ]]></body>
<body><![CDATA[<p><font face="Verdana" size="2">We concluded that, in Andalusia, specific IBD units are present in most hospitals. These units have become essential due to their functionality, the need for a proper doctor-patient relationship, and their role in reducing direct and indirect public health costs.</font></p>     <p>&nbsp;</p>     <p><font face="Verdana"><b>References</b></font></p>     <!-- ref --><p><font face="Verdana" size="2">1. Loftus EV Jr. Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences. Gastroenterology 2004; 126: 1504-17.</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=5322190&pid=S1130-0108200900030000500001&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p><font face="Verdana" size="2">2. Loftus EV Jr, Silverstein MD, Sandborn WJ, Tremaine WJ, Harmsen WS, Zinsmeister AR. Crohn's disease in Olmsted County, Minnesota, 1940-1993: incidence, prevalence, and survival. Gastroenterology 1998; 114: 1161-8.</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=5322191&pid=S1130-0108200900030000500002&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p><font face="Verdana" size="2">3. Loftus EV Jr, Silverstein MD, Sandborn WJ, Tremaine WJ, Harmsen WS, Zinsmeister AR. Ulcerative colitis in Olmsted County, Minnesota, 1940-1993: incidence, prevalence, and survival. Gut 2000; 46: 336-43.</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=5322192&pid=S1130-0108200900030000500003&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p><font face="Verdana" size="2">4. Bernstein CN, Blanchard JF, Rawsthorne P, Wajda A. Epidemiology of Crohn's disease and ulcerative colitis in a central Canadian province: a population-based study. Am J Epidemiol 1999; 149: 916-24.</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=5322193&pid=S1130-0108200900030000500004&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p><font face="Verdana" size="2">5. Pajares JM, Gisbert JP. Epidemiology of inflammatory bowel disease in Spain. A systematic review. Rev Esp Enferm Dig 2001; 93: 9-20.</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=5322194&pid=S1130-0108200900030000500005&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p><font face="Verdana" size="2">6. Saro Gismera C, Riestra Men&eacute;ndez S, S&aacute;nchez Fern&aacute;ndez R, Milla Crespo A, Lacort Fern&aacute;ndez M, Arg&uuml;elles Fern&aacute;ndez G, et al. Epidemiology in inflammatory bowel disease in five areas of Asturias. Spain. An Med Interna 2003; 20(5): 232-8.</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=5322195&pid=S1130-0108200900030000500006&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p><font face="Verdana" size="2">7. Garrido A, Mart&iacute;nez MJ, Ortega JA, Lobato A, Rodr&iacute;guez MJ, Guerrero FJ. Epidemiology of chronic inflammatory bowel disease in the Northern area of Huelva. Rev Esp Enferm Dig 2004; 96(10): 687-91; 691-4.</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=5322196&pid=S1130-0108200900030000500007&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p><font face="Verdana" size="2">8. Estudio Prospectivo Delphi. Costes Sociales y Econ&oacute;micos de la Enfermedad Inflamatoria Intestinal (EII). Faes Farma (eds.) 2005.</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=5322197&pid=S1130-0108200900030000500008&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p><font face="Verdana" size="2">9. Kennedy A, Robinson A, Nelson E, Rogers A, Reeves D, Sculpher M, et al. A randomised controlled trial to assess the impact of a package comprising a patient-orientated, evidence-based self-help guidebook and patient-centred consultations on disease management and satisfaction in inflammatory bowel disease. Health Technology Assessment 2003; 7(28).</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=5322198&pid=S1130-0108200900030000500009&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p><font face="Verdana" size="2">10. Herrer&iacute;as Guti&eacute;rrez JM, Arg&uuml;elles Arias F, Mart&iacute;n Herrera L, Montero Dom&iacute;nguez JM, de Dios Vega J, Mart&iacute;n-Vivaldi Mart&iacute;nez R, et al. A high-resolution gastroenterology clinic in Andalusia: what is it, and how should it work. Rev Esp Enferm Dig 2008; 100(1): 5-10.</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=5322199&pid=S1130-0108200900030000500010&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p><font face="Verdana" size="2">11. Herrer&iacute;as Guti&eacute;rrez JM, Arg&uuml;elles Arias F; Andalusian Team of Chiefs of Gastroenterology Units and Departments. Results of a survey in Andalusian endoscopy units. Rev Esp Enferm Dig 2006; 98(12): 929-48.</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=5322200&pid=S1130-0108200900030000500011&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p><font face="Verdana" size="2">12. Pan&eacute;s J, Lacy AM, Sans M, Soriano A, Piqu&eacute; JM. Elevado &iacute;ndice de consultas por internet de los pacientes catalanes con enfermedad inflamatoria intestinal. Gastroenterol Hepatol 2001; 25: 306-9.</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=5322201&pid=S1130-0108200900030000500012&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p><font face="Verdana" size="2">13. Nightingale AJ, Middleton W, Middleton SJ, Hunter JO. Evaluation of the effectiveness of a specialist nurse in the management of inflammatory bowel disease (IBD). Eur J Gastroenterol Hepatol. 2000; 12(9): 967-73.</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=5322202&pid=S1130-0108200900030000500013&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p><font face="Verdana" size="2">14. Casellas F, Fontanet G, Borruel N, Malagelada JR. The opinion of patients with inflammatory bowel disease on healthcare received. Rev Esp Enferm Dig 2004; 96(3): 174-84.</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=5322203&pid=S1130-0108200900030000500014&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p><font face="Verdana" size="2">15. Miller L, Caton S, Lynch D. Telephone clinic improves quality of follow-up care for chronic bowel disease. Nurs Times 2002; 98: 36-8.</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=5322204&pid=S1130-0108200900030000500015&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p><font face="Verdana" size="2">16. Kennedy AP, Nelson E, Reeves D, Richardson, Roberts, Robinson A, et al. A randomised controlled trial to assess the effectiveness and cost of a patient orientated self management approach to chronic inflammatory bowel disease. Gut 2004; 53: 1639-45.</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=5322205&pid=S1130-0108200900030000500016&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p><font face="Verdana" size="2">17. Robinson A, Thompson DG, Wilkin D, Roberts C. Guided self-management and patient-directed follow-up of ulcerative colitis: a randomised trial. Lancet 2001; 358: 976-81.</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=5322206&pid=S1130-0108200900030000500017&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p><font face="Verdana" size="2">18. Saibil F, Lai E, Hayward A, Yip J, Gilbert C. Self-management for people with inflammatory bowel disease. Can J Gastroenterol 2008; 22(3): 281-7.</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=5322207&pid=S1130-0108200900030000500018&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><p>&nbsp;</p>     <p>&nbsp;</p>     <p><font face="Verdana" size="2"><b><a href="#top"><img border="0" src="/img/revistas/diges/v101n3/seta.gif" width="15" height="17"></a> <a name="bajo"></a>Correspondence:</b>    <br>Juan Manuel Herrerías Gutiérrez.    <br>Servicio de Aparato Digestivo.    <br>Hospital Universitario Virgen Macarena.    <br>Avda. doctor Fedriani, s/n.    <br>41071 Sevilla, Spain.    <br>e-mail: <a href="mailto:jmhg@us.es">jmhg@us.es</a></font></p>     ]]></body>
<body><![CDATA[<p><font face="Verdana" size="2">Received: 09-01-09.    <br>Accepted: 13-01-09.</font></p>      ]]></body><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Loftus]]></surname>
<given-names><![CDATA[EV Jr]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences]]></article-title>
<source><![CDATA[Gastroenterology]]></source>
<year>2004</year>
<volume>126</volume>
<page-range>1504-17</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Loftus]]></surname>
<given-names><![CDATA[EV Jr]]></given-names>
</name>
<name>
<surname><![CDATA[Silverstein]]></surname>
<given-names><![CDATA[MD]]></given-names>
</name>
<name>
<surname><![CDATA[Sandborn]]></surname>
<given-names><![CDATA[WJ]]></given-names>
</name>
<name>
<surname><![CDATA[Tremaine]]></surname>
<given-names><![CDATA[WJ]]></given-names>
</name>
<name>
<surname><![CDATA[Harmsen]]></surname>
<given-names><![CDATA[WS]]></given-names>
</name>
<name>
<surname><![CDATA[Zinsmeister]]></surname>
<given-names><![CDATA[AR]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Crohn's disease in Olmsted County, Minnesota, 1940-1993: incidence, prevalence, and survival]]></article-title>
<source><![CDATA[Gastroenterology]]></source>
<year>1998</year>
<volume>114</volume>
<page-range>1161-8</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Loftus]]></surname>
<given-names><![CDATA[EV Jr]]></given-names>
</name>
<name>
<surname><![CDATA[Silverstein]]></surname>
<given-names><![CDATA[MD]]></given-names>
</name>
<name>
<surname><![CDATA[Sandborn]]></surname>
<given-names><![CDATA[WJ]]></given-names>
</name>
<name>
<surname><![CDATA[Tremaine]]></surname>
<given-names><![CDATA[WJ]]></given-names>
</name>
<name>
<surname><![CDATA[Harmsen]]></surname>
<given-names><![CDATA[WS]]></given-names>
</name>
<name>
<surname><![CDATA[Zinsmeister]]></surname>
<given-names><![CDATA[AR]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Ulcerative colitis in Olmsted County, Minnesota, 1940-1993: incidence, prevalence, and survival]]></article-title>
<source><![CDATA[Gut]]></source>
<year>2000</year>
<volume>46</volume>
<page-range>336-43</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bernstein]]></surname>
<given-names><![CDATA[CN]]></given-names>
</name>
<name>
<surname><![CDATA[Blanchard]]></surname>
<given-names><![CDATA[JF]]></given-names>
</name>
<name>
<surname><![CDATA[Rawsthorne]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Wajda]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Epidemiology of Crohn's disease and ulcerative colitis in a central Canadian province: a population-based study]]></article-title>
<source><![CDATA[Am J Epidemiol]]></source>
<year>1999</year>
<volume>149</volume>
<page-range>916-24</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Pajares]]></surname>
<given-names><![CDATA[JM]]></given-names>
</name>
<name>
<surname><![CDATA[Gisbert]]></surname>
<given-names><![CDATA[JP]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Epidemiology of inflammatory bowel disease in Spain: A systematic review]]></article-title>
<source><![CDATA[Rev Esp Enferm Dig]]></source>
<year>2001</year>
<volume>93</volume>
<page-range>9-20</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Saro Gismera]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Riestra Menéndez]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Sánchez Fernández]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Milla Crespo]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Lacort Fernández]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Argüelles Fernández]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Epidemiology in inflammatory bowel disease in five areas of Asturias. Spain]]></article-title>
<source><![CDATA[An Med Interna]]></source>
<year>2003</year>
<volume>20</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>232-8</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Garrido]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Martínez]]></surname>
<given-names><![CDATA[MJ]]></given-names>
</name>
<name>
<surname><![CDATA[Ortega]]></surname>
<given-names><![CDATA[JA]]></given-names>
</name>
<name>
<surname><![CDATA[Lobato]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Rodríguez]]></surname>
<given-names><![CDATA[MJ]]></given-names>
</name>
<name>
<surname><![CDATA[Guerrero]]></surname>
<given-names><![CDATA[FJ]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Epidemiology of chronic inflammatory bowel disease in the Northern area of Huelva]]></article-title>
<source><![CDATA[Rev Esp Enferm Dig]]></source>
<year>2004</year>
<volume>96</volume>
<numero>10</numero>
<issue>10</issue>
<page-range>687-91; 691-4</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="book">
<source><![CDATA[Estudio Prospectivo Delphi: Costes Sociales y Económicos de la Enfermedad Inflamatoria Intestinal (EII)]]></source>
<year>2005</year>
<publisher-name><![CDATA[Faes Farma]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kennedy]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Robinson]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Nelson]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Rogers]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Reeves]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Sculpher]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[A randomised controlled trial to assess the impact of a package comprising a patient-orientated, evidence-based self-help guidebook and patient-centred consultations on disease management and satisfaction in inflammatory bowel disease]]></article-title>
<source><![CDATA[Health Technology Assessment]]></source>
<year>2003</year>
<volume>7</volume>
<numero>28</numero>
<issue>28</issue>
</nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Herrerías Gutiérrez]]></surname>
<given-names><![CDATA[JM]]></given-names>
</name>
<name>
<surname><![CDATA[Argüelles Arias]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Martín Herrera]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Montero Domínguez]]></surname>
<given-names><![CDATA[JM]]></given-names>
</name>
<name>
<surname><![CDATA[de Dios Vega]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Martín-Vivaldi Martínez]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[A high-resolution gastroenterology clinic in Andalusia: what is it, and how should it work]]></article-title>
<source><![CDATA[Rev Esp Enferm Dig]]></source>
<year>2008</year>
<volume>100</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>5-10</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Herrerías Gutiérrez]]></surname>
<given-names><![CDATA[JM]]></given-names>
</name>
<name>
<surname><![CDATA[Argüelles Arias]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
</person-group>
<collab>Andalusian Team of Chiefs of Gastroenterology Units and Departments</collab>
<article-title xml:lang="en"><![CDATA[Results of a survey in Andalusian endoscopy units]]></article-title>
<source><![CDATA[Rev Esp Enferm Dig]]></source>
<year>2006</year>
<volume>98</volume>
<numero>12</numero>
<issue>12</issue>
<page-range>929-48</page-range></nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Panés]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Lacy]]></surname>
<given-names><![CDATA[AM]]></given-names>
</name>
<name>
<surname><![CDATA[Sans]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Soriano]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Piqué]]></surname>
<given-names><![CDATA[JM]]></given-names>
</name>
</person-group>
<article-title xml:lang="es"><![CDATA[Elevado índice de consultas por internet de los pacientes catalanes con enfermedad inflamatoria intestinal]]></article-title>
<source><![CDATA[Gastroenterol Hepatol]]></source>
<year>2001</year>
<volume>25</volume>
<page-range>306-9</page-range></nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Nightingale]]></surname>
<given-names><![CDATA[AJ]]></given-names>
</name>
<name>
<surname><![CDATA[Middleton]]></surname>
<given-names><![CDATA[W]]></given-names>
</name>
<name>
<surname><![CDATA[Middleton]]></surname>
<given-names><![CDATA[SJ]]></given-names>
</name>
<name>
<surname><![CDATA[Hunter]]></surname>
<given-names><![CDATA[JO]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Evaluation of the effectiveness of a specialist nurse in the management of inflammatory bowel disease (IBD)]]></article-title>
<source><![CDATA[Eur J Gastroenterol Hepatol.]]></source>
<year>2000</year>
<volume>12</volume>
<numero>9</numero>
<issue>9</issue>
<page-range>967-73</page-range></nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Casellas]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Fontanet]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Borruel]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Malagelada]]></surname>
<given-names><![CDATA[JR]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[The opinion of patients with inflammatory bowel disease on healthcare received]]></article-title>
<source><![CDATA[Rev Esp Enferm Dig]]></source>
<year>2004</year>
<volume>96</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>174-84</page-range></nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Miller]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Caton]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Lynch]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Telephone clinic improves quality of follow-up care for chronic bowel disease]]></article-title>
<source><![CDATA[Nurs Times]]></source>
<year>2002</year>
<volume>98</volume>
<page-range>36-8</page-range></nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kennedy]]></surname>
<given-names><![CDATA[AP]]></given-names>
</name>
<name>
<surname><![CDATA[Nelson]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Reeves]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Richardson]]></surname>
<given-names><![CDATA[Roberts]]></given-names>
</name>
<name>
<surname><![CDATA[Robinson]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[A randomised controlled trial to assess the effectiveness and cost of a patient orientated self management approach to chronic inflammatory bowel disease]]></article-title>
<source><![CDATA[Gut]]></source>
<year>2004</year>
<volume>53</volume>
<page-range>1639-45</page-range></nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Robinson]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Thompson]]></surname>
<given-names><![CDATA[DG]]></given-names>
</name>
<name>
<surname><![CDATA[Wilkin]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Roberts]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Guided self-management and patient-directed follow-up of ulcerative colitis: a randomised trial]]></article-title>
<source><![CDATA[Lancet]]></source>
<year>2001</year>
<volume>358</volume>
<page-range>976-81</page-range></nlm-citation>
</ref>
<ref id="B18">
<label>18</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Saibil]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Lai]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Hayward]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Yip]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Gilbert]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Self-management for people with inflammatory bowel disease]]></article-title>
<source><![CDATA[Can J Gastroenterol]]></source>
<year>2008</year>
<volume>22</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>281-7</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
